• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Impact of Angiographic Result After Predilatation on Outcome After Drug-Coated Balloon Treatment of In-Stent Coronary Restenosis.

作者信息

Tanaka Akihito, Latib Azeem, Jabbour Richard J, Kawamoto Hiroyoshi, Giannini Francesco, Ancona Marco, Regazzoli Damiano, Mangieri Antonio, Mattioli Roberto, Chieffo Alaide, Carlino Mauro, Montorfano Matteo, Colombo Antonio

机构信息

Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy; Interventional Cardiology Unit, San Raffaele Scientific Institute & San Raffaele University, Milan, Italy.

Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy; Interventional Cardiology Unit, San Raffaele Scientific Institute & San Raffaele University, Milan, Italy; Imperial College London, London, United Kingdom.

出版信息

Am J Cardiol. 2016 Nov 15;118(10):1460-1465. doi: 10.1016/j.amjcard.2016.08.006. Epub 2016 Aug 24.

DOI:10.1016/j.amjcard.2016.08.006
PMID:27634028
Abstract

This study investigates clinical outcomes after drug-coated balloon (DCB) treatment for in-stent restenosis (ISR) based on the angiographic result achieved after predilatation and before DCB treatment. Among ISR lesions treated with DCBs, 166 lesions with angiography immediately after predilatation were analyzed. The lesions were divided into 2 groups according to angiographic results after predilatation: (1) "adequate" defined as the presence of Thrombolysis In Myocardial Infarction 3 flow, residual stenosis ≤30%, and no major dissections (n = 98 lesions) or (2) "inadequate" (n = 68 lesions). The reference vessel diameters were larger (2.88 ± 0.39 vs 2.64 ± 0.52 mm, p = 0.001) and lesion lengths shorter in the adequate group (15.4 ± 11.2 vs 19.7 ± 13.9 mm, p = 0.04). During a median follow-up of 808 days, the cumulative target lesion revascularization (TLR) rate was lower in the adequate group (20.3% vs 35.5% at 2 years; p = 0.04). Multivariate analysis indicated that an angiographically inadequate result before DCB treatment was an independent predictor of TLR, even after adjusting for reference vessel diameter and lesion length (hazard ratio 1.99, 95% confidence interval 1.02 to 3.87, p = 0.04). In conclusion, angiographic results after lesion preparation appear to be a good predictor of TLR after DCB treatment for ISR.

摘要

相似文献

1
Impact of Angiographic Result After Predilatation on Outcome After Drug-Coated Balloon Treatment of In-Stent Coronary Restenosis.
Am J Cardiol. 2016 Nov 15;118(10):1460-1465. doi: 10.1016/j.amjcard.2016.08.006. Epub 2016 Aug 24.
2
Drug-Coated Balloons Versus Second-Generation Drug-Eluting Stents for the Management of Recurrent Multimetal-Layered In-Stent Restenosis.药物涂层球囊与第二代药物洗脱支架治疗复发性多层药物洗脱支架内再狭窄。
JACC Cardiovasc Interv. 2015 Oct;8(12):1586-94. doi: 10.1016/j.jcin.2015.04.032. Epub 2015 Sep 17.
3
Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study.紫杉醇涂层球囊导管与紫杉醇涂层支架治疗冠状动脉支架内再狭窄:PEPCAD II ISR研究的三年结果
EuroIntervention. 2015 Dec;11(8):926-34. doi: 10.4244/EIJY14M08_12.
4
Treatment of large de novo coronary lesions with paclitaxel-coated balloon only: results from a Chinese institute.单纯紫杉醇涂层球囊治疗新发大冠状动脉病变:来自中国研究机构的结果。
Clin Res Cardiol. 2019 Mar;108(3):234-243. doi: 10.1007/s00392-018-1346-8. Epub 2018 Aug 3.
5
Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.药物洗脱支架置入治疗无保护左主干冠状动脉疾病后,冠状动脉解剖结构和支架技术对长期预后的影响。
JACC Cardiovasc Interv. 2014 Jan;7(1):29-36. doi: 10.1016/j.jcin.2013.08.013. Epub 2013 Dec 11.
6
Treatment of Very Small De Novo Coronary Artery Disease With 2.0 mm Drug-Coated Balloons Showed 1-Year Clinical Outcome Comparable With 2.0 mm Drug-Eluting Stents.使用2.0毫米药物涂层球囊治疗非常小的初发冠状动脉疾病显示,1年临床结果与2.0毫米药物洗脱支架相当。
J Invasive Cardiol. 2018 Jul;30(7):256-261. Epub 2018 Apr 15.
7
Mid-term clinical outcomes after bailout drug-eluting stenting for suboptimal drug-coated balloon results: Insights from a Milan registry.药物涂层球囊治疗效果不佳行补救性药物洗脱支架置入术后的中期临床结局:来自米兰注册研究的观察。
Int J Cardiol. 2018 Jul 15;263:17-23. doi: 10.1016/j.ijcard.2018.04.050. Epub 2018 Apr 13.
8
Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).紫杉醇涂层球囊与球囊血管成形术治疗的长期结果:PEPCAD-DES 研究的见解(使用 SeQuent Please 紫杉醇涂层经皮腔内冠状动脉血管成形术 [PTCA] 导管治疗药物洗脱支架 [DES] 支架内再狭窄)。
JACC Cardiovasc Interv. 2015 Nov;8(13):1695-700. doi: 10.1016/j.jcin.2015.07.023.
9
The clinical characteristics and prognosis of lesions with in-stent eccentric tissue proliferation and strong signal attenuation detected by optical coherence tomography.光学相干断层扫描检测到的支架内偏心组织增生和强信号衰减病变的临床特征及预后
Cardiovasc Interv Ther. 2016 Jul;31(3):210-7. doi: 10.1007/s12928-015-0369-6. Epub 2015 Nov 25.
10
Treatment of drug-eluting stents in-stent restenosis with paclitaxel-coated balloon angioplasty: Insights from the French "real-world" prospective GARO Registry.使用紫杉醇涂层球囊血管成形术治疗药物洗脱支架内再狭窄:来自法国“真实世界”前瞻性GARO注册研究的见解。
Int J Cardiol. 2016 Jan 15;203:690-6. doi: 10.1016/j.ijcard.2015.11.031. Epub 2015 Nov 6.

引用本文的文献

1
Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.用于冠状动脉疾病的药物涂层球囊:从理论到实践
Curr Treat Options Cardiovasc Med. 2025 Dec;27(1). doi: 10.1007/s11936-025-01084-4. Epub 2025 Mar 19.
2
Clinical Implication of Quantitative Flow Ratio to Predict Clinical Outcomes in De Novo Coronary Lesions After Drug-Coated Balloon Angioplasty.定量血流比预测药物涂层球囊血管成形术后初发冠状动脉病变临床结局的临床意义
Cardiovasc Drugs Ther. 2025 Jun 20. doi: 10.1007/s10557-025-07735-9.
3
Drug coated balloons in percutaneous coronary intervention: how can computational modelling help inform evolving clinical practice?
经皮冠状动脉介入治疗中的药物涂层球囊:计算模型如何助力优化临床实践?
Front Med Technol. 2025 Apr 30;7:1546417. doi: 10.3389/fmedt.2025.1546417. eCollection 2025.
4
Pantera Lux Drug-Coated Balloon for the Treatment of Coronary Artery Lesions in Routine Practice.用于常规临床实践中治疗冠状动脉病变的Pantera Lux药物涂层球囊
J Clin Med. 2025 May 1;14(9):3133. doi: 10.3390/jcm14093133.
5
Drug-coated balloons in percutaneous coronary interventions: existing evidence and emerging hopes.经皮冠状动脉介入治疗中的药物涂层球囊:现有证据与新希望
Cardiol J. 2025;32(3):308-320. doi: 10.5603/cj.101393. Epub 2025 Apr 14.
6
Enhanced Drug Effect With Cutting Balloon Followed by Drug Coated Balloon in a Rabbit Model.在兔模型中,切割球囊联合药物涂层球囊增强药物效果。
Catheter Cardiovasc Interv. 2025 Jun;105(7):1656-1663. doi: 10.1002/ccd.31505. Epub 2025 Mar 20.
7
Drug-Coated Balloon Treatment for De Novo Coronary Lesions: Current Status and Future Perspectives.药物涂层球囊治疗初发冠状动脉病变:现状与未来展望
Korean Circ J. 2024 Sep;54(9):519-533. doi: 10.4070/kcj.2024.0148. Epub 2024 Jun 3.
8
Chinese expert consensus on the clinical application of drug-coated balloon (2 Edition).药物涂层球囊临床应用中国专家共识(第2版)
J Geriatr Cardiol. 2024 Feb 28;21(2):135-152. doi: 10.26599/1671-5411.2024.02.001.
9
Drug-coated balloons for the treatment of ostial left anterior descending or ostial left circumflex artery lesions: a patient-level propensity score-matched analysis.用于治疗左前降支开口或左旋支开口动脉病变的药物涂层球囊:一项患者水平倾向评分匹配分析。
J Geriatr Cardiol. 2023 Oct 28;20(10):716-727. doi: 10.26599/1671-5411.2023.10.005.
10
Drug-coated balloon: an effective alternative to stent strategy in small-vessel coronary artery disease-a meta-analysis.药物涂层球囊:小血管冠状动脉疾病中支架策略的有效替代方案——一项荟萃分析
Front Cardiovasc Med. 2023 Aug 21;10:1213992. doi: 10.3389/fcvm.2023.1213992. eCollection 2023.